Non-Cochrane · intervention · PM41561408

Can Mesenchymal Stem Cells Improve Bone Regeneration in Maxillary Sinus Augmentation? A Systematic Review and Meta-Analysis.

Coronel-Zubiate Franz Tito, Marroquín-Soto Consuelo, Luján-Valencia Sara Antonieta, et al. · Stem cells international · 2026 · PubMed · doi:10.1155/sci/6656563

Findings

12 findings

Population
Adults with posterior maxillary atrophy requiring maxillary sinus augmentation before dental implant placementMesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft)Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft)Bone regeneration success (presence or absence of new bone formation, dichotomous)
Leave-one-out sensitivity analysis omitting Wildburger et al.
RR 1.22 [0.73, 2.04]
GRADE not reported
2 studies
Adults with posterior maxillary atrophy requiring maxillary sinus augmentation before dental implant placementMesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft)Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft)Implant success rate
Leave-one-out sensitivity analysis omitting Wildburger et al.
log RR -0.03 [-0.10, 0.04]
GRADE not reported
4 studies
Adults with posterior maxillary atrophy undergoing maxillary sinus augmentation before dental implant placementMesenchymal stem cell (MSC)-based bone regenerationConventional grafting without stem cells (DBBM, autograft, allograft or blood clot)Bone regeneration (continuous)
Maxillary sinus lift
SMD -0.83 [-1.37, -0.30]
High
2 studies
Adults with posterior maxillary atrophy requiring maxillary sinus augmentation before dental implant placementMesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft)Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft)Implant success rate
Leave-one-out sensitivity analysis omitting Bajestan et al.
log RR -0.01 [-0.06, 0.03]
GRADE not reported
4 studies
Adults with posterior maxillary atrophy requiring maxillary sinus augmentation before dental implant placementMesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft)Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft)Implant success rate
Leave-one-out sensitivity analysis omitting Gupta et al.
log RR -0.03 [-0.09, 0.04]
GRADE not reported
4 studies
Adults with posterior maxillary atrophy requiring maxillary sinus augmentation before dental implant placementMesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft)Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft)Implant success rate
Follow-up 3 to 12 months
RR 0.98 [0.94, 1.03]
Moderate
Downgraded: inconsistency
5 studies · 222 implants participants
Adults with posterior maxillary atrophy requiring maxillary sinus augmentation before dental implant placementMesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft)Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft)Implant success rate
Leave-one-out sensitivity analysis omitting Payer et al.
log RR -0.03 [-0.10, 0.04]
GRADE not reported
4 studies
Adults with posterior maxillary atrophy requiring maxillary sinus augmentation before dental implant placementMesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft)Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft)Bone regeneration success (presence or absence of new bone formation, dichotomous)
Leave-one-out sensitivity analysis omitting Rickert et al.
RR 1.16 [0.70, 1.93]
GRADE not reported
2 studies
Adults with posterior maxillary atrophy requiring maxillary sinus augmentation before dental implant placementMesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft)Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft)Bone regeneration (bone neoformation, continuous)SMD -0.84 [-1.36, -0.32]
High
2 studies · 60 participants
Adults with posterior maxillary atrophy requiring maxillary sinus augmentation before dental implant placementMesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft)Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft)Bone regeneration success (presence or absence of new bone formation, dichotomous)
Leave-one-out sensitivity analysis omitting Payer et al.
RR 1.03 [0.63, 1.69]
GRADE not reported
2 studies
Adults with posterior maxillary atrophy requiring maxillary sinus augmentation before dental implant placementMesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft)Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft)Implant success rate
Leave-one-out sensitivity analysis omitting Rickert et al.
log RR -0.00 [-0.05, 0.04]
GRADE not reported
4 studies
Adults with posterior maxillary atrophy requiring maxillary sinus augmentation before dental implant placementMesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft)Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft)Bone regeneration success (presence or absence of new bone formation, dichotomous)RR 1.11 [0.73, 1.67]
High
3 studies

Included primary studies 6

Open in Studies
StudyYearAlso included byOutcomes it informs hereTrial data
Bajestan 2017
Stem cell therapy for reconstruction of alveolar cleft and trauma defects in adults: A randomized controlled, clinical trial.
PMID:28656723
20172 other reviewsImplant success rate; Bone regeneration (bone neoformation, continuous)not extracted yet
Gupta 2021
A comparative evaluation of bone regeneration using mesenchymal stem cells versus blood coagulum in sinus augmentation procedures.
PMID:35153430
20212 other reviewsImplant success rate; Bone regeneration (bone neoformation, continuous)not extracted yet
Payer 2014
Effects of directly autotransplanted tibial bone marrow aspirates on bone regeneration and osseointegration of dental implants.
PMID:23701676
20142 other reviewsImplant success rate; Bone regeneration success (presence or absence of new bone formation, dichotomous)not extracted yet
Whitt 2020
Efficacy of stem cell allograft in maxillary sinus bone regeneration: a randomized controlled clinical and blinded histomorphometric study.
PMID:32596764
20202 other reviewsnot statednot extracted yet
Rickert 2014
Maxillary sinus floor elevation surgery with BioOss® mixed with a bone marrow concentrate or autogenous bone: test of principle on implant…
PMID:24183511
20141 other reviewImplant success rate; Bone regeneration success (presence or absence of new bone formation, dichotomous)not extracted yet
Wildburger 2014
Impact of autogenous concentrated bone marrow aspirate on bone regeneration after sinus floor augmentation with a bovine bone…
PMID:23875876
20141 other reviewImplant success rate; Bone regeneration success (presence or absence of new bone formation, dichotomous)not extracted yet

Overlap with other reviews

Reviews that include the same primary studies are not independent evidence. Shared counts match studies by PMID, DOI or NCT, and otherwise by author and year (a probable match). Only the non-Cochrane dental reviews have study lists, so overlap with Cochrane reviews is not counted yet.

Review question

ElementPlanned (methods)Found (results)
PopulationAdults presenting with posterior maxillary atrophy requiring maxillary sinus augmentation before dental implant placementAdults undergoing maxillary sinus lift (74 patients, 222 implants; 6 RCTs)
InterventionTreatment with mesenchymal stem cells for bone regenerationMSC-based grafts: bone marrow aspirate concentrate, peripheral blood MSCs, MSC allograft (n=6)
ComparisonBone regeneration procedures without stem cells (e.g., platelet concentrates, autologous grafts, biomaterials)DBBM, autograft, allograft or blood clot without MSCs (n=6)
OutcomesBone neoformation rate or percentage, bone quality, healing time; implant success rate (exploratory)Implant success rate (n=5); bone regeneration, continuous (n=2); bone regeneration present, dichotomous (n=3)
Study designsRandomized or nonrandomized clinical trialsRCTs (n=6); four split-mouth
TimingNot specifiedFollow-up 4 to 12 months

AMSTAR 2 items

Two independent extractors rated each item. Their ratings are shown side by side because they have not been reconciled yet. The overall rating follows Shea et al. 2017: one critical flaw gives Low, more than one gives Critically Low.

ItemExtractor AExtractor BAgree
1Research question includes PICO componentsYesYesyes
2Protocol established before the reviewcriticalPartial YesPartial Yesyes
3Choice of study designs explainedYesYesyes
4Comprehensive literature searchcriticalPartial YesPartial Yesyes
5Study selection in duplicateYesYesyes
6Data extraction in duplicateYesYesyes
7List of excluded studies with reasonscriticalYesYesyes
8Included studies described in detailPartial YesPartial Yesyes
9Risk of bias assessed satisfactorilycriticalRCT: Yes · NRSI: N/ANRSI: N/A · RCT: Yesno
10Funding of included studies reportedNoNoyes
11Appropriate meta-analysis methodscriticalRCT: No · NRSI: N/ANRSI: N/A · RCT: Partial Yesno
12Impact of risk of bias on the pooled resultsYesYesyes
13Risk of bias accounted for in interpretationcriticalYesYesyes
14Heterogeneity explainedYesYesyes
15Publication bias investigatedcriticalNoNoyes
16Conflicts of interest reportedYesYesyes
OverallCritically LowLowno